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Abstract
Dengue viruses (DENV) serotypes 1, 2, and 3 have been causing yearly outbreaks in Brazil. In this study, we report the re-
introduction of DENV2 in the coast of Sa ˜o Paulo State. Partial envelope viral genes were sequenced from eighteen patients
with dengue fever during the 2010 epidemic. Phylogenetic analysis showed this strain belongs to the American/Asian
genotype and was closely related to the virus that circulated in Rio de Janeiro in 2007 and 2008. The phylogeny also showed
no clustering by clinical presentation, suggesting that the disease severity could not be explained by distinct variants or
genotypes. The time of the most recent common ancestor of American/Asian genotype and the Sa ˜o Paulo and Rio de
Janeiro (SP/RJ) monophyletic cluster was estimated to be around 40 and 10 years, respectively. Since this virus was first
identified in Brazil in 2007, we suggest that it was already circulating in the country before causing the first documented
outbreak. This is the first description of the 2010 outbreak in the State of Sa ˜o Paulo, Brazil, and should contribute to efforts
to control and monitor the spread of DENVs in endemic areas.
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Introduction
Dengue is the most prevalent arthropod-born viral disease in
tropical and subtropical regions, infecting 50 to 100 million people
annually [1]. Cases in Central and Latin America have increased
almost five-fold in the last 30 years. In 2008, up to one million
cases were reported in the Americas, with higher number of deaths
occurred in the Southern Cone [2]. In the last two decades, Brazil
has been responsible for more than 60% of the total reported
dengue fever cases in the Americas [2]. The continuing occurrence
in resource limited countries and the lack of novel therapeutic
approaches or an effective vaccine have made dengue fever to be
considered a neglected disease. Dengue surveillance is deprived in
most countries and no existing model for predicting an outbreak in
endemic regions is available.
The mechanisms by which dengue virus (DENV) causes severe
illness remain to be elucidated. Both viral and immune host factors
seem to contribute to the level of the pathogenicity [3,4,5,6].
Immunity induced by natural infection is believed to provide
serotype-specific lifelong protection. On the other hand, previous
infection by a distinct serotype increases the risk for dengue
hemorrhagic fever and dengue shock syndrome (DHF/DSS) [5,7].
In the Americas, DHF wasfirst reported inCuba in1981 after the
introduction of the DENV2 genotype from Southeast Asian (SEA)
[8,9]. Since then, other countries in the Americas have reported
DHF associated with such DENV2 genotype, but not with the
American genotype [9]. In Brazil, DENV2 was first identified in the
State of Rio de Janeiro in 1990, where the first cases of DHF and
DSS were documented [10]. It was followed by a fast spread of
DENV2 across the country [11,12], becoming endemic in some
areas [13] and causing severe clinical forms [14]. Genomic analysis
performed on DENV2 Brazilian isolates identified the co-circulation
oftwodistinctlineagesoftheAmericanandAsiangenotypes[15,16].
In a recent study, Oliveira et al. reported that the virus circulating in
the State of Rio de Janeiro in 2007 and 2008 was genetically distinct
from 1990 and 1998 isolates from respective epidemics, suggesting a
local evolution of the DENV2 strain or, alternatively, a co-
circulation of distinct lineages in the country [15]. In the beginning
of 2010, several dengue outbreaks have been documented in many
regions of Brazil, with the co-circulation of three serotypes (DENV1,
2, and 3). By the end of March 2010, the Sa ˜o Paulo State Healthy
Department reported more than 34,000 cases of dengue, more than
800 only in the coast cities of Guaruja ´ and Santos, where severe
clinical presentations have been observed (64 deaths related to
dengueoccurredinthe sametimeframeinthe Sa ˜oPauloState)[17].
In this study we characterized at molecular and phylogenetic
levels the DENV2 strain causing the current epidemic in the
coastal cities of Guaruja ´ and Santos and surrounding areas. Using
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this specific lineage entered in Brazil.
Methods
Ethics Statement
The current project was conducted after Hospital das Clı ´nicas -
University of Sa ˜o Paulo’s Institutional Review Board (CAPPesq)
approval, under protocol #0652/09. Written informed consent
was obtained from all participants.
Clinical samples and virus Isolation
Serum samples were obtained from patients with clinical
suspected dengue fever at the Ana Costa Hospital located in the
city of Santos, State of Sa ˜o Paulo. DENV2 was successfully
isolated from 18 serum samples by inoculation into monolayers of
C6/36 Aedes albopictus cell line (ATCC number CRL-1660).
Supernatants from cell cultures presenting cytopathic effect
compatible with DENV infection were assayed by reverse
transcriptase polymerase chain reaction (RT-PCR) to amplify
serotype-specific viral genome.
RNA extraction and RT-PCR
Viral RNA was isolated directly from 140 ml of cell culture
supernatants using the QIAamp Viral RNA Mini Kit (Qiagen,
Valencia, USA) following the manufacturer’s instructions. cDNA
was synthesized using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Foster City, CA). A total
reaction volume of 20 ml was made with 10 ml of RNA and 10 ml
of mix, containing 2.0 ml1 0 6buffer, 0.8 ml dNTP Mix (100 mM),
2.0 ml1 0 6random hexamer primers, 1.0 ml reverse transcriptase
and 4.2 ml nuclease-free water.
PCR amplification and sequencing
A 665 bp of envelope region corresponding to nucleotides 1857
to 2522 of DENV2 complete genome (GenBank reference
sequence DQ181801) was amplified by PCR using following
primers specific for DENV2: D2_EnvF -59- AARRTYGTRAAR-
GAAATAGCAGAA-39 and D2_EnvOutR- 59-CTGTCCAYG-
TRTGYACGTTRTCT-39. The thermal profile for amplification
was 38 cycles of 45 seconds of denaturation at 94uC, 1 minute of
annealing at 56uC, and 1 minute of extension at 72uC. The PCR
products were purified for elimination of primer dimmer and
excess oligonucleotides with the PureLink Quick Gel extraction
Kit (Invitrogen), with few adaptations for direct purification of
PCR products in solution. Sequencing reactions were performed
with BigDye Terminator kit v.3.0 (Applied Biosystems, Bedford,
MA) and one of each primer used in sequencing reaction. The
eletropherograms were analyzed and consensus sequences were
achieved with CodonCode Aligner v.3.0 (available at http://www.
codoncode.com/).
Phylogenetic and coalescent analysis
The 18 sequences generated were aligned together with
reference sequences downloaded from GenBank using the
ClustalX program [18]. An initial dataset including our sequences
and reference sequences from all four serotypes (n=93) was used
to confirm that our samples were truly DENV2. A second dataset
included our samples and reference sequences of all DENV2
genotypes known to cause outbreaks around the word (n=91).
The phylogenetic trees were reconstructed using a Bayesian
Markov Chain Monte Carlo (MCMC) framework implemented in
BEAST v1.5.3 [19]. The GTR+G substitution model was used as
the best model obtained in MODELTEST [20]. Also, the
previously estimated substitution rate for DENV2 of
6.5610
24 s/s/y [21] was used to obtain the time of the most
recent common ancestor (TMRCA) for the American/Asian
genotype and also for the Brazilian DENV2. The Bayesian Skyline
plot (BSL) was performed under strict and relaxed uncorrelated
lognormal molecular clock. The molecular clock that best fitted
the data was chosen by Bayes factor (BF) comparison. Conver-
gence of parameters during the MCMC was inspected with Tracer
v.1.4 [19], with uncertainties addressed as 95% highest probability
density (HPD) intervals. In all cases, ten million chains were
sufficient to achieve the convergence of all parameters (ESS.200).
The trees were sampled at each 1000 steps, resulting in a final file
of 10,000 trees. These trees were summarized in a maximum clade
credibility (MCC) tree using TreeAnotator (part of the BEAST
package), and visualized in FigTree v.1.2.2 (http://beast.bio.ed.ac.
uk/FigTree).
Results
An initial phylogenetic tree including all DENV serotypes
confirmed, with high posterior probability, that our samples
belong to serotype 2 (supplementary Figure S1). The maximum
clade credibility (MCC) tree (Figure 1) showed that the DENV2
isolates circulating in 2010 in Guaruja ´ and Santos clustered within
the American/Asian genotype and were closely related to viruses
that caused the epidemics in Rio de Janeiro during 2007 and 2008
[15]. Although this study included only two patients with severe
dengue (patients 28 and 42, Table 1), the phylogenetic tree showed
no segregation by clinical manifestations, since mild and severe
dengue fever cases samples clustered together. Moreover, we
found no differences at aminoacid level in the envelope region
among patients with distinct clinical presentations. However, it
must be taken into account that differences in clinical manifesta-
tion may not be evident by our analysis, since they included a
limited number of patients and encompassed only partial envelope
gene. Age, gender and further clinical data are described in
Table 1.
Importantly, the monophyletic cluster of the recent Brazilian
DENV2 was closely related to viral strains from Cuba and the
Dominican Republic, with small genetic distance and high
posterior probability, suggesting that this lineage was imported
from the Caribbean.
The coalescent analysis based on the dataset containing the five
DENV2 genotypes revealed that the lineage causing the epidemics
in the last four years in Brazil was introduced in the country at
least at 5.5 years ago (median value of 9.8 years ago, and upper
value of 16 years ago). Importantly, Figure 1 also showed that our
estimates for the time of the most recent common ancestor
(TMRCA) of the key nodes covered essentially the same range as
those estimated by previous reports [21,22], further supporting our
results. The TMRCA data described here were obtained under
relaxed uncorrelated molecular clock. Although the relaxed clock
was the best model by Bayes Factor comparison, the coalescent
dates obtained under the strict clock were similar (Supplementary
Files S1 A and B).
The sequences generated in this work were submitted to
GenBank database under accession numbers HM185186 to
HM185202.
Discussion
Our phylogenetic analysis based on the partial DENV2
envelope gene sequencing showed that viruses causing the current
epidemic in the cities of Guaruja ´ and Santos, as well as
surrounding areas, were sister taxa of those sampled two years
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presence of Aedes aegypti and the frequent traveling amongst such
regions are the necessary ingredients for viral spread through
viremic patients moving between these cities.
It was interesting to find that the lineage causing outbreaks in
Brazil in the end of 90’s, the isolates from Northeast Brazil between
2001 and 2006, and the viruses representing more recent epidemics
(2007 to 2010) in Sa ˜o Paulo and Rio de Janeiro States segregated
into temporal sub-clades (Figure 1). Several longitudinal studies
have also observed temporal clustering of dengue, as well as marked
patterns of geographical structure [23,24,25]. The circulation of
distinct lineages of DENV2 in Brazil had already been observed
before [15] and was ascribed either to independent introductions in
different time points or as a result of local evolution.
The sequences distribution in the phylogenetic tree indicated
that the oldest Brazilian DENV2 are more related to viruses from
South American countries (Paraguay and Venezuela), and the
more recent isolate appears to be a result of a re-introduction from
the Caribbean (Martinique, Cuba, and the Dominican Republic).
In fact, migration of DENV2 from the Caribbean islands into
America’s mainland was reported to be relatively frequent [26].
However, due to the low availability of sequences from other
South American countries, we could not precisely determine the
location of such introduction.
It is well known that DENV is characterized by frequent clade
replacements (i.e., the replacement of the successful lineage present
in one sampling period to the next) [25]. Also, this ‘‘lineage
turnover’’ phenomenon appears to be a consequence of the
stochastic forces and host immunity pressures, which ultimately
determines the prevalence of a specific clade or serotype in a
particular season [25,27]. This model agrees to both conditions
observed during the recent epidemics in Brazil: (i) the shift from
DENV3 to DENV2 prevalence in the Southern region and, (ii) the
emergence of a genetically distinct lineage of DENV2 in 2007,
possibly caused by the re-introduction of viruses imported from the
Caribbean. Although phylogenetic data show that some strains
can persist and locally evolve, our data on DENV2 in Brazil
suggest that the re-introduction may be important for the
dynamics of the epidemics.
The evolutionary history of dengue virus is recent and DENV2
is estimated to have emerged between 120 and 215 years ago
[21,22,28], which is in line with our prediction of 123 years for this
serotype. Additionally, we estimated that the American/Asian
genotype emerged about 40 years ago, which is also in accordance
to previous data of 39 years for the origin of this genotype [21].
However, it was intriguing that the viruses causing the outbreaks
in Sa ˜o Paulo and Rio de Janeiro States during the last three years
share a common ancestor few years before the first reported
Figure 1. Phylogenetic tree of DENV2 Brazilian samples. The maximum clade credibility (MCC) tree was inferred for 18 partial envelope
sequences from the city of Santos, State of Sa ˜o Paulo and DENV2 reference sequences. The posterior probabilities of the key nodes are depicted
above the respective node. The time of the most recent common ancestor (TMRCA) of the more recent lineage, American/Asian genotype and
serotype 2, with upper and lower intervals in parenthesis, are depicted in bold in the respective nodes. Black full circles identify the sequences
generated in this study. Brazilian sequences are identified according to the region of origin: ‘‘North‘‘ (from Northeast region) and ‘‘SP’’ or ‘‘RJ’’ (from
Southeast region). When available, the sampling year was described in the end of the sequences.
doi:10.1371/journal.pone.0011811.g001
Table 1. Characteristics of the 18 patients sampled in Santos (2010) with DENV2 disease.
Patient ID City Gender Age (years) Platelets (61000/ml) Clinical presentation* Death
05 Sa ˜o Vicente Female 25 174 Dengue fever No
07 Santos Female 34 253 Dengue fever No
10 Guaruja ´ Female 37 152 Dengue fever No
11 Santos Male 53 179 Dengue fever No
13 Sa ˜o Vicente Female 74 120 Dengue fever No
16 Santos Female 22 200 Dengue fever No
17 Santos Male 47 237 Dengue fever No
18 ND** Female 16 39 ND** Yes
25 ND** Male 50 48 Dengue fever No
28 Santos Male 79 17 Severe (DSS) Yes
42 Santos Female 86 20 Severe (DHF) No
44 Sa ˜o Vicente Female 29 216 Dengue fever No
45 Santos Male 31 230 Dengue fever No
47 Santos Female 31 147 Dengue fever No
49 Santos Male 51 158 Dengue fever No
51 Santos Female 53 135 Dengue fever No
52 Santos Female 46 132 Dengue fever No
327 Santos Female 0*** ND** Dengue fever No
*The patients presenting severe dengue must present at least one of the follow clinical findings: plasma leakage (leading to DSS and/or respiratory distress); severe
bleeding and severe organ involvement. This has been defined by the World Health Organization Guideline, 2009.
**ND not determined.
***one week.
doi:10.1371/journal.pone.0011811.t001
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ago), suggesting that this lineage was already circulating in Brazil
before its detection in 2007.
In fact, a ‘‘silent’’ introduction of a new DENV into a naı ¨ve
population has already been documented for DENV4 in Brazil
[29,30]. In 2008, DENV4 was identified in three patients in
Manaus, without international travelling history. Based on these
data, we can envisage the possibility that the DENV2 found Sa ˜o
Paulo and Rio de Janeiro States has maintained a cryptic
circulation in such regions or elsewhere (as well as DENV4 in
Manaus), until meets favourable conditions to trigger an outbreak.
Because the introduction of a new serotype in an endemic area
may imply in more severe clinical presentations of dengue disease,
our findings shed lights on the importance of a more systematic
surveillance of the dengue viruses in endemic regions.
In summary, this work described the molecular and phyloge-
netic characteristics of DENV2 during the current outbreak in the
coastal region of Sao Paulo State, Brazil. The present epidemic in
the cities of Guaruja ´, Santos and surrounding areas, was caused by
the same DENV2 lineage that circulated in Rio de Janeiro in 2007
and 2008, but distinct from viruses that circulated during more
ancient DENV2 epidemics in Brazil. Also, since the introduction
of a new serotype is considered to increase the risk for severe
dengue, our data on the silent introduction of DENV2 claims for
the risks of cryptic introduction and circulation of new viruses into
endemic areas.
This work supports the importance of dengue surveillance
improvement and may help developing dengue-control programs.
Finally, it is important to remember that the infectious disease
dynamic is more than a local problem, involving neighboring
regions and the population migration rate. Surveillance programs
during non-epidemic seasons and in non-endemic regions may be
crucial for early identification of new dengue virus introduction.
Supporting Information
File S1 A. TMRCA of the DENV2 obtained by Strict and
Relaxed Uncorrelated Lognormal Molecular Clock. B. Bayes
factor values obtained for molecular clock comparison of DENV2.
Found at: doi:10.1371/journal.pone.0011811.s001 (0.03 MB
DOC)
Figure S1 Phylogenetic tree of the four DENV serotypes. The
maximum clade credibility (MCC) tree was inferred from 93
partial envelope dengue viruses sequences obtained from patients
from the cities of Guaruja ´ and Santos (collapsed blue clade) and
representative sequences of all DENV serotypes. The posterior
probabilities of the key nodes are depicted above the respective
node.
Found at: doi:10.1371/journal.pone.0011811.s002 (2.95 MB TIF)
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